The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Imidazol-1-ylmethyl-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-ethyl ester 3-methyl ester: hydrochloride ID: ALA1203626
Max Phase: Preclinical
Molecular Formula: C21H23ClN4O6
Molecular Weight: 426.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCO/C(O)=C1\C(C)=NC(Cn2ccnc2)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1.Cl
Standard InChI: InChI=1S/C21H22N4O6.ClH/c1-4-31-21(27)17-13(2)23-16(11-24-9-8-22-12-24)19(20(26)30-3)18(17)14-6-5-7-15(10-14)25(28)29;/h5-10,12,18,27H,4,11H2,1-3H3;1H/b21-17+;
Standard InChI Key: HJRUVIXVMHLWIA-DIRYEVLESA-N
Molfile:
RDKit 2D
32 33 0 0 0 0 0 0 0 0999 V2000
7.6969 0.3751 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.8916 -4.9570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2526 1.3618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2524 0.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4979 -1.0529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0317 -0.7359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0351 3.6026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3064 4.9494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 0.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1969 1.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1945 3.0046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8943 3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5964 3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8888 5.2533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8478 5.8502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9260 5.8568 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
9 16 1 0
16 17 2 0
17 6 1 0
17 18 1 0
8 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
7 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
27 29 1 0
29 30 2 0
29 31 1 0
5 32 1 0
M CHG 2 29 1 31 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 426.43Molecular Weight (Monoisotopic): 426.1539AlogP: 3.28#Rotatable Bonds: 7Polar Surface Area: 129.08Molecular Species: ACIDHBA: 9HBD: 1#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.30CX Basic pKa: 6.76CX LogP: 1.66CX LogD: 0.97Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.31Np Likeness Score: -1.18
References 1. Archibald JL, Bradley G, Opalko A, Ward TJ, White JC, Ennis C, Shepperson NB.. (1990) Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridines., 33 (2): [PMID:2299629 ] [10.1021/jm00164a028 ]